<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03600688</url>
  </required_header>
  <id_info>
    <org_study_id>2017-10</org_study_id>
    <nct_id>NCT03600688</nct_id>
  </id_info>
  <brief_title>Edwards Cardioband European Post-Market Study, MiBAND</brief_title>
  <acronym>MiBAND</acronym>
  <official_title>Transcatheter Repair of Mitral Regurgitation With Cardioband System Post Market Study:A European Prospective, Multicenter Study to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System in Patients With Symptomatic MR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate reduction of MR with durable performance and im-provements in functional
      status
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MiBAND is a prospective, single arm, European post-market study to assess the safety and
      efficacy of the Edwards Cardioband system. Patients will be followed up at 30D, 6months, 1, 2
      and 3 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 6, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Procedure Success at discharge</measure>
    <time_frame>Hospital discharge; approximately 2-8 days post-procedure</time_frame>
    <description>Reduction in Severity of Mitral Regurgitation at discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure Success</measure>
    <time_frame>30 days, 6months, 1, 2 and 3 years</time_frame>
    <description>Reduction in Severity of Mitral Regurgitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Events Rate</measure>
    <time_frame>30 days, 6months, 1, 2 and 3 years</time_frame>
    <description>Rate of Major Adverse Events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality Of Life-KCCQ</measure>
    <time_frame>30 days, 6 months, 1, 2 and 3 years</time_frame>
    <description>Improvements in Quality Of Life as assessed by KCCQ</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality Of Life-EQ-5D-5L</measure>
    <time_frame>30 days, 6 months, 1, 2 and 3 years</time_frame>
    <description>Improvements in Quality Of Life as assessed by EQ-5D-5L</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Mitral Regurgitation</condition>
  <condition>Mitral Insufficiency</condition>
  <condition>Mitral Repair</condition>
  <condition>Mitral Valve</condition>
  <condition>Annuloplasty</condition>
  <condition>Edwards Cardioband</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Edwards Cardioband System</intervention_name>
    <description>Transcatheter mitral valve repair</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Symptomatic patients with mitral regurgitation (MR).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

          -  Age ≥ 18 years;

          -  MR (≥ 2+ by echocardiography);

          -  Patient is eligible to receive the Edwards Cardioband Mitral System

        Main Exclusion Criteria:

          -  Active bacterial endocarditis

          -  Severe organic lesions with retracted chordae or congenital mal-formations with lack
             of valvular tissue

          -  Heavily calcified annulus or leaflets

          -  Patients in whom transesophageal echocardiography is contraindicated

          -  Patients who cannot tolerate an anticoagulation/antiplatelet regimen

          -  Patients with known severe reaction to contrast agents that cannot be adequately
             pre-medicated.

          -  Pre-existing prosthetic heart valve or annuloplasty in the Mitral position

          -  Life expectancy of less than twelve months

          -  Patient is pregnant or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan Baldus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herzzentrum UniKlinik Köln</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Maisano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Zürich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edwards TMTT Clinical Affairs</last_name>
    <phone>+1 949 250 2500</phone>
    <email>TMTT_clinical@edwards.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW Bad Oeynhausen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kai Friedrichs, MD</last_name>
      <email>kfriedrichs@hdz-nrw.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Berlin Charité - Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katja Hubert</last_name>
      <email>Katja.Hubert@charite.de</email>
    </contact>
    <investigator>
      <last_name>Alexander Lauten, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Nickenig, MD</last_name>
      <email>Georg.Nickenig@ukbonn.de</email>
    </contact>
    <investigator>
      <last_name>Georg Nickenig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum UniKlinik Köln</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Heinrichs</last_name>
      <email>ana.heinrichs@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Baldus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Universitästklinik Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Linke, MD</last_name>
      <email>linkea@medizin.uni-leipzig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Düsseldorf University Hospital</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rabea Wagtsaff</last_name>
      <email>Rabea.Wagstaff@med.uni-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Ralf Westenfeld, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Goethe-University Frankfurt - Surgery Center</name>
      <address>
        <city>Frankfurt am main</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Walther, MD</last_name>
      <email>Claudia.Walther@kgu.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Göttingen</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Swetlana Hartmann</last_name>
      <email>swetlana.hartmann@med.uni-goettingen.de</email>
    </contact>
    <investigator>
      <last_name>Claudius Jacobshagen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St Georg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sakine Struck</last_name>
      <email>s.struck@asklepios.com</email>
    </contact>
    <investigator>
      <last_name>Christian Frerker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universtitätsmedizin Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilka Walther</last_name>
      <email>ilka.walther@unimedizin-mainz.de</email>
    </contact>
    <investigator>
      <last_name>Ralph Stephan von Bardeleben, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Hellige</last_name>
      <email>antje.hellige@ukmuenster.de</email>
    </contact>
    <investigator>
      <last_name>Helmut Baumgartner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Vittorio-Emanuelle</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmelo Grasso, MD</last_name>
      <email>carmelograssomd@pec.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale del Cuore G. Pasquinucci - Fondazione Toscana Gabreile Monasterio</name>
      <address>
        <city>Massa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppa Lo Surdo, Dott</last_name>
      <email>glosurdo@ftgm.it</email>
    </contact>
    <investigator>
      <last_name>Sergio Berti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Denti, MD</last_name>
      <email>paolo.denti@hsr.it</email>
    </contact>
    <investigator>
      <last_name>Azeem Latib, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiara Primerano</last_name>
      <email>chiaraprim@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Anna Sonia Petronio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico San Donato</name>
      <address>
        <city>San Donato Milanese</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Bianchi</last_name>
      <email>Giovanni.Bianchi@grupposandonato.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Zürich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simone Frank</last_name>
      <email>Simone.Frank@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Francesco Maisano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>June 15, 2018</study_first_submitted>
  <study_first_submitted_qc>July 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>December 19, 2019</last_update_submitted>
  <last_update_submitted_qc>December 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

